Latest AI and machine learning research in preventive care for healthcare professionals.
BACKGROUND: Effective screening and cohort enrichment remain major challenges in clinical trials for Alzheimer's disease (AD), where traditional diagnostic pathways rely on costly, invasive, and time-consuming procedures. Speech and language analysis has emerged as a scalable, low-burden approach for detecting subtle cognitive-linguistic and motor-speech changes that may appear early in the diseas...
BACKGROUND: Artificial intelligence (AI) is increasingly recognized for its potential to transform cancer care. However, much of the existing evidence of its efficacy comes from controlled settings. There remains a need to complement this knowledge with insights into how AI tools are perceived and used in real-world clinical settings, as well as how their use impacts clinical practice. OBJECTIVE: ...
BACKGROUND: Athletes frequently experience potentially traumatic events related to sports injuries, significantly increasing their risk of developing ...
We present a high-throughput screening approach to identifying safer nonaqueous solvents to replace or modify the flammable, carbonate-based solvents ...
Intertwining supply chains integrates the corresponding networks across several intersection points, such as suppliers, manufacturers, and transporter...
Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) is a key enzyme in amyloid-β generation and remains an important target in Alzheimer's d...
Acute leukemias (ALs) are a diverse group of hematological malignancies characterized by the abnormal proliferation of immature cells. Microscopic obs...
INTRODUCTION: Teicoplanin is commonly used to treat Gram-positive bacterial infections in the intensive care unit (ICU). However, evidence to support ...
BACKGROUND: Artificial intelligence (AI) is increasingly being explored in trauma care as a tool to support clinical decision-making. OBJECTIVE: To ev...
Global implementation of gastric cancer (GC) screening in chronic dyspepsia populations faces challenges due to the high number-needed-to-scope (NNS) ...
Artificial intelligence (AI) is an accurate screening tool for diabetic retinopathy (DR), the leading cause of blindness among working-aged adults. Ho...
OBJECTIVE: Public willingness to accept medical artificial intelligence (AI) tools affect the potential real-world impact of these evolving technologi...
Screening of heart failure (HF) remains suboptimal. However, vocal biomarkers are an emerging tool to screen for HF and predict adverse outcomes. This...
BACKGROUND: Colorectal cancer (CRC) remains a leading cause of cancer-related mortality, necessitating the development of more selective and safer the...
PURPOSE: Artificial intelligence (AI)-based screening models hold promise for identifying individuals with undiagnosed age-related macular degeneratio...
AIMS: To assess the diagnostic agreement between an artificial intelligence (AI) system and general practitioners (GPs) interpreting fundus photograph...
PURPOSE: To determine whether a high-quality, prospectively curated dataset can, by itself, enable the development of robust and clinically effective ...
MOTIVATION: Global population aging has led to a rapid increase in neurodegenerative disorders such as alzheimer's disease (AD). Although existing dru...
BACKGROUND/AIMS: Deep learning algorithms have shown promise for glaucoma detection using retinal imaging. The Northern Finland Birth Cohort Eye Study...
Interest in large language models (LLMs) as a tool for meta-analyses and systematic reviews (MA/SRs) is growing. We prospectively developed 515 unique...